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 Although surgical site infections (SSIs) are known to cause
substantial illness and costs during the index hospitalization, lit-
tle information exists about the impact of infections diagnosed
after discharge, which constitute the majority of SSIs. In this
study, using patient questionnaire and administrative data-
bases, we assessed the clinical outcomes and resource utiliza-
tion in the 8-week postoperative period associated with SSIs
recognized after discharge. SSI recognized after discharge was
confirmed in 89 (1.9%) of 4,571 procedures from May 1997 to
October 1998. Patients with SSI, but not controls, had a signifi-
cant decline in SF-12 (Medical Outcomes Study 12-Item Short-
Form Health Survey) mental health component scores after
surgery (p=0.004). Patients required significantly more outpa-
tient visits, emergency room visits, radiology services, readmis-
sions, and home health aide services than did controls.
Average total costs during the 8 weeks after discharge were
US$5,155 for patients with SSI and $1,773 for controls
(p<0.001). 
urgical site infections (SSIs), the second most common
cause of nosocomial infection after urinary tract infec-
tions, cause approximately 17% of all hospital-acquired infec-
tions (1) and lead to increased costs and worse patient
outcomes in hospital inpatients (2). The Centers for Disease
Control and Prevention estimates that approximately 500,000
SSIs occur annually in the United States (3). Costs and out-
comes secondary to SSIs can vary by location and surgery
type. Infections in cardiac surgery have been estimated to add
from US$8,200 (1982 dollars) to $42,000 (1985 dollars) to the
cost of care after adjustments are made for preexisting ill-
nesses and conditions, and these increased costs are likely
attributable to excess hospital and intensive care unit stays (4–
6). Overall, SSIs may result in $1–$10 billion in direct and
indirect medical costs each year (3,7). 
With the current trends favoring a shortened postoperative
hospital stay, outpatient surgery, and same-day surgery, more
SSIs are occurring after discharge from the hospital and, there-
fore, beyond the reach of most hospital infection control sur-
veillance programs (8). Of all surgical procedures, 75% are
now estimated to occur in the outpatient or ambulatory setting,
and for those that do occur in the inpatient setting, postopera-
tive length of stay is decreasing (9). An estimated 47% to 84%
of SSIs occur after discharge; most of these are managed
entirely in the outpatient setting (8,10).
Given the high costs and adverse patient outcomes associ-
ated with SSIs, quantifying the clinical and economic impact
of SSIs recognized after discharge from the hospital is impor-
tant. Several studies have focused on the direct medical costs
borne by the hospital or insurer, but to our knowledge, no
study has assessed the full societal impact of SSIs, which
includes indirect costs, such as lost patient productivity and
diminished functional status (11,12). Additionally, no study
has addressed the costs of SSIs that arise from most of these
infections which now occur in the postdischarge setting and
for which patients are not readmitted to the index hospital. The
magnitude of these costs might not be known if ascertainment
were left solely to the index hospital’s information systems. 
Methods
This study used a matched cohort design to compare the
costs and illness of patients with an SSI to matched patients
who had surgery during the same period but in whom an SSI
did not develop. The study population was drawn from adult
members of Harvard Vanguard Medical Associates, a 250,000-
member multispecialty group practice, which at the time of the
study was a staff model component of Harvard Pilgrim Health
Care, a health maintenance organization. Study participants
were those who had undergone a nonobstetric inpatient or out-
patient operating room procedure at Brigham and Women’s
Hospital from May 18, 1997, through October 31, 1998. Cases
of SSI were identified prospectively by using an established
method of automated medical record screening for 102 diag-
nostic, testing, or treatment codes that may have indicated the
occurrence of an SSI in the outpatient setting (13). In addition,
pharmacy records were screened for antibiotic dispensing, and
claims were screened for hospital readmissions or emergency
room visits pertaining to an SSI. Surgeries were identified in
2-week cycles, and a total of 38 cycles were completed. An
investigator reviewed those records judged to indicate a post-
discharge SSI by initial screening, using the National Nosoco-
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mial Infections Surveillance criteria during the 30-day
postoperative period to confirm infection (14). Patients who
had an SSI that occurred during the index hospitalization were
excluded. Case-patients were individually matched on surgery
type, age and duration of surgical procedure in a ratio of one
case-patient to two other members of the cohort. 
Questionnaire
Participants were enrolled 5–7 weeks after surgery. All
case-patients and matched pairs were mailed a 49-item ques-
tionnaire, an explanatory letter, and a consent form. The ques-
tionnaire contained three sections. The first section had
questions designed to assess illness, which were taken from
the National Health Interview Survey, and additional questions
designed to quantify care and resource use during the 8-week
postoperative period, including home visits, phone calls to
practitioners, missed days from work, and family members’
missed days from work (15). The second and third sections
were each designed to assess health-related quality of life by
using the Medical Outcomes Study 12-Item Short-Form
Health Survey (SF-12) during the 8 weeks after surgery and
the 4 weeks before surgery, respectively (16). Patients were
instructed to recall their overall health since surgery and their
health before surgery. Patients who did not return question-
naires were followed up with phone calls and re-mailing of the
survey. If they did not return the questionnaire within 90 days,
they were considered nonresponders. If questionnaires were
incomplete, the answers that were provided were included in
the analyses. SF-12 mental and physical scores (MCS-12 and
PCS-12, respectively) were normalized by using standard
methods to obtain mean scores (16). 
Administrative Databases
Four administrative databases were used to determine pro-
vider-level resource use associated with the 8 weeks after dis-
charge from the operation that led to entry into the cohort. The
Harvard Pilgrim Health Care demographic database was used
to capture patient date of birth, gender, and zip code. This
health maintenance organization maintains an automated
administrative claims system that houses all charges from ven-
dors, including hospitals, and outside the ambulatory-care cen-
ters. This database included the associated discharge date for
index surgery, from which we calculated the 8 weeks’ postop-
erative time window for our analysis and from which we
counted the resource utilization across all databases. This data-
base provided all charges between the vendor or facility and
the health maintenance organization, length of stay, procedure
codes, diagnosis codes, and pharmacy codes for all encounters
that occurred outside of the health plan. Thus, any readmis-
sion, emergency room visit, skilled nursing facility stay, or
home health aide charge appeared in this database. 
In addition, Harvard Pilgrim Health Care maintained an
automated ambulatory medical record system that captured all
ambulatory encounters and orders at its health centers. This
database allowed determination of the number of outpatient
visits, telephone calls, and most laboratory tests. This database
also captures the number of inpatient physician encounters
made by the health maintenance organization’s patients. Costs
associated with outpatient visits at the health centers were
imputed by using the costs for CPT Codes 99213–99215 from
the 1998 National Physician Fee Schedule Relative Value File
(available from: URL: http://www.hcfa.gov/stats/pufiles.htm).
The first visit for each case-patient with an SSI was assumed
to be an established-patient visit lasting 40 minutes (CPT
99215), and the first visit for those without an SSI was
assumed to last 25 minutes (CPT 99214). All subsequent visits
for all patients were assumed to last 15 minutes (CPT 99213).
Costs in 1998 for CPT codes 99213, 99214, and 99215 were
$41.46, $62.74, and $99.06, respectively.
Harvard Pilgrim Health Care also maintains a database that
captures all pharmacy prescriptions dispensed in the outpatient
setting (17). This database provided the standard wholesale
costs for all antibiotic prescriptions for the 8-week postopera-
tive period. 
Chronic disease scores, as a marker for patient preexisting
conditions and illnesses, have been shown to be predictors of
SSI and also of death, hospitalization, and resource utilization
(18–21). The chronic disease score, as used here, is a method
for controlling for preexisting conditions on the basis of
patient age, gender, and recent history of drug dispensing. This
score predicts for hospitalization (22) and SSI (19) and thus
would appear to be a useful adjuster for preexisting conditions
in our cost analysis. For each patient, a chronic disease score
was created by using patient age, sex, and presence or absence
of 29 chronic diseases, calculated from the 6-month preopera-
tive ambulatory pharmacy dispensing record (18,19). 
Attributable charges of SSI recognized after discharge
were calculated by taking the mean charges of case-patients
and subtracting the mean charges of control patients. Mean
charges were chosen for this comparison since the use of
medians would negate the effect that even a moderately rare
event (those that occur in <50% of the study population)
would have on health-care costs. For those areas of resource
utilization in which only charges were available, charges were
converted to costs by using a cost-to-charges ratio. Since this
study involved readmission and resource utilization at several
different hospitals, conversion to costs would have required
institution-specific ratios of costs to charge, to which we did
not have access. We have, therefore, chosen to use a published
ratio of costs to charges from a cohort of 4,108 patients admit-
ted in the same city to two hospitals, one of which was the
index hospital in this study, and during a similar period to this
study (23). 
Statistics
Student t test, Wilcoxon rank-sum test, or Fisher exact test
were used, where appropriate, for univariate comparisons.
Outcomes are presented as medians with interquartile range,
means with standard deviations, or proportions. Cases and
matched controls were compared by using the WilcoxonRESEARCH
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signed-ranks test for continuous outcomes with non-normal
distributions, continuous linear regression by forcing the
matching variable into the model for normally distributed vari-
ables, or the Cochran-Mantel-Haenszel for matched binary
variables. Almost all assessed utilization outcomes, including
all charges, were non-normally distributed so both medians
with interquartile range and means with standard deviation are
reported. Multivariable unconditional logistic regression was
used to control for confounding variables in the analysis of the
questionnaire data, and all matched variables were forced into
the model to account for the matching process. 
Since combined total costs and charges (ambulatory, phar-
macy, and nonambulatory) of the entire cohort of 267 patients
were log-normally distributed, the total cost variable was ana-
lyzed by using a log-transformation of total costs in a matched
linear regression model. To estimate the effect that preexisting
conditions or index surgery duration might have on the attrib-
utable effect of SSI on total costs, a matched linear regression
with log-transformed total costs as the outcome was created
with the predictors SSI/no SSI, chronic disease score (CDS),
and index surgery duration entered as variables into the model.
Results are given as β -estimates of effect, R-square statistic,
and p value for five models (only SSI versus no SSI; only
CDS; both SSI versus no SSI and CDS; both SSI versus no SSI
and index surgery duration; and all three variables: SSI, CDS,
and duration of index surgery). All statistical tests were two-
tailed; p <0.05 was considered statistically significant. Statisti-
cal analyses were performed with SAS v 8.01 for Windows
(SAS Institute, Inc., Cary, NC).
During the anticipated study period, 3,000 surgeries would
be estimated to be performed and, given a 2.8% risk for infec-
tion beginning after discharge from the hospital (based on our
prior observations), 84 SSIs would be recognized after dis-
charge. This gave a power of 0.89 to detect >5 days lost from
usual activities. Our actual sample of SSIs recognized after
discharge was 89 (1.9%) from a sample of 4,571 procedures. 
All data collected were combined into one dataset for final
analysis, after which all unique identifiers were removed. In
addition, each patient provided a signed consent form before
completing the questionnaire and being enrolled in the study.
The Harvard Pilgrim Health Care institutional review board
approved this study. 
Results
SSI recognized after discharge was confirmed in 89 (1.9%)
of 4,571 procedures. One hundred seventy-eight patients with
similar age, procedure types, and surgical duration were
matched to the SSI patients in a ratio of one case-patient to two
controls (Table 1). No significant differences in age, gender, or
surgery type between case-patients and matched controls were
noted. Surgery duration was significantly longer for SSI
patients, despite having been matched for procedure duration.
This was expected because procedure duration is an important
risk factor for infection. 
Table 1. Descriptive characteristics of cohort in study of surgical site 
infections (SSI), Harvard Pilgrim Health Care, 1997–1998a
Characteristic
Case-patients
N (% or SDa)
Controls
N (% or SDa)p  v a l u e
Study cohort N=267 89 178
Demographics of complete cohort 
Age (yr) 55.8 (+/-14.6) 57.5 (+/-13.3) 0.33b
Male gender 43 (48.3) 94 (52.8) 0.52c
Surgery duration (min) 177 (+/-112) 137 (+/-74) 0.037d
Chronic disease score 3,058 (+/-2636) 2,148 (+/-2285) 0.005d
Surgery location (inpatient) 73 (82) 149 (83.7) 1.0c
Surgery type
 Cardiac 26 (29.2) 53 (29.8) 1.0c
 General 25 (28.1) 53 (29.8) 0.89c
 Gynecology 2 (2.3) 4 (2.3) 1.0c
 Neurology 4 (4.5) 8 (4.5) 1.0c
 Orthopedic 15 (16.9) 32 (18) 0.87c
 Other 2 (2.3) 3 (1.7) 1.0c
 Plastic 5 (5.6) 6 (3.4) 0.51c
 Urology 3 (3.4) 6 (3.4) 1.0c
 Vascular 7 (7.9) 13 (7.3) 1.0c
Description of questionnaire responders
Responder N=173 (65%) 50 (56.2) 123 (69.1) 0.042c
Age (yr) 57.3 (+/-13.7) 58.6 (+/-12.4) 0.54b
Male gender 25 (50) 69 (56.1) 0.50c
Surgery duration (min) 185 (+/-142) 144 (+/-81) 0.19d
Surgery type
 Cardiac 16 (32) 39 (31.7) 1.0c
 General 18 (36.0) 35 (28.5) 0.37c
 Gynecology 1 (2.0) 3 (2.4) 1.0c
 Neurology 1 (2.0) 6 (4.9) 0.67c
 Orthopedic 7 (14.0) 23 (18.7) 0.51c
 Other 1 (2.0) 0 (0.0) 0.29c
 Plastic 2 (4.0) 3 (2.4) 0.63c
 Urology 1 (2.0) 4 (3.3) 1.0c
 Vascular 3 (6.0) 10 (8.1) 0.76c
Occupation (could check >1)
 Employed 26.6% 30.8% 0.61c
 Homemaker 29.8% 28.2% 0.85c
 Retired 42.9% 61.5% 0.07c
 Student 2.1% 2.5% 1.0c
Preexisting medical conditionse
 Congestive heart failure 12.2% 2.5% 0.018c
 Diabetes 24.5% 11.5% 0.057c
 Arthritis 38.8% 21.5% 0.034c
aResults are shown as no. (%) or mean +/- standard deviation, along with p value for 
comparison of cases with SSIs to controls without SSIs.
bStudent t test.
cFisher exact test.
dWilcoxon rank-sum test. 
eThirteen additional preexisting conditions were assessed, including chronic lung dis-
ease, vision or hearing impairment, asthma, peptic ulcer disease, chronic back pain, 
hypertension, angina, myocardial infarction, stroke, kidney disease, and cancer; all were 
not significantly different between cases and controls with p>0.05.Emerging Infectious Diseases  •  Vol. 9, No. 2, February 2003 199
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Impact on Health, Activities, and Perceived Care Needs
One hundred seventy-three (65%) of 267 questionnaires
were returned. Those who completed the questionnaire
(responders) were slightly older than those that did not
respond (58.2 years vs. 54.6 years, p=0.05). No other differ-
ences between questionnaire responders and nonresponders
were significant (Tables 2 and 3). Among patients who com-
pleted the questionnaire, no differences between case-patients
and controls were significant for age, sex, and procedure types
(Table 1), or in the baseline SF-12 assessment of mental and
physical health (Table 3). Reported occupations of patients and
controls did not differ, and few differences between case-
patients and controls existed with respect to self-declared dif-
ferences in pre-existing medical conditions (Table 1). Case-
patients did experience longer duration of surgery than did
controls. Case-patients were also more likely than controls to
report a history of congestive heart failure (12% vs. 2.5%,
p=0.02) and arthritis (39% vs. 22%, p=0.03). There was a
trend towards more case-patients having diabetes than controls
(24% vs. 12% p=0.06). 
In assessing time and productivity costs, we found that
case-patients (64%) were more likely than controls (42%) to
have spent at least 1/2 day in bed, thus missing planned regular
activities (p=0.04). However, differences between case-
patients and controls in other areas of lost productivity, such as
missed days of work and inability to complete regular activi-
ties, were not significant. 
Case-patients with an SSI (69%) were more likely than
controls (48%) to require home health provider visits (p=0.01).
Similar results were found after controlling for age, procedure
duration, and baseline SF-12 physical function. There were
trends for patients with SSI wanting more home health visits
than were provided and wanting a 24-hour hotline to contact a
health-care practitioner. Patients, but not controls, reported
significantly lower physical health and mental health compo-
nent scores on the SF-12 after surgery, compared to their own
baselines (p=0.003 and p=0.02, respectively). 
Health Resource Use in 8 Weeks after Surgery
Patients with SSI recognized after discharge required sig-
nificantly more resources within the outpatient setting than
those without SSI (Table 4). Significantly more patients with
SSI had at least one ambulatory-care visit, and their average
number of visits (7.5) was more than twice the average of
those without SSI (3.4). Additionally, case-patients were sig-
nificantly more likely to call their provider and to make more
phone calls to their provider than controls. The number of lab-
oratory tests ordered did not differ between cases and controls.
Estimated ambulatory outpatient visits costs generated were
on average $365 per case with an SSI and $160 per control
during the 8-week postoperative period (p<0.001). 
Patients with an SSI recognized after discharge also used
significantly more resources outside of the ambulatory-care
centers. More case-patients (31%) had at least one visit to an
emergency room compared to controls (9%), p<0.001, and
they generated significantly more emergency room charges
($333 vs. $114, p<0.001). 
Those with SSI were more likely to require a radiology test
(40% vs. 28%, p=0.02) and had higher radiology test charges
($1,076 vs. $587, p=0.02) than those without SSI. More
patients with an SSI received durable medical equipment than
did controls (37% vs. 22%, p=0.008) and generated higher
average durable medical equipment–related charges ($123 vs.
$69, p=0.01). A greater proportion of case-patients (62%) than
controls (47%) required home health services (p=0.009).
Charges related to home health services were higher for those
with an SSI ($827) than for those without an SSI ($579),
p=0.007. Twice as many case-patients required a stay in a
skilled nursing facility (9% vs. 4.5%, p=0.09). There was a
nonsignificant trend towards higher average skilled nursing
charges for case-patients ($460 vs. $204 p=0.14); however, the
average number of days in a skilled nursing facility was the
same for case-patients and controls.
Patients with an SSI recognized after discharge generated
higher standard wholesale costs for antibiotics than did con-
trols without an SSI. Case-patients had an average cost of $60
for antibiotics, while controls had costs of $13.60 per person
(p<0.001). Patients with an SSI were more likely to be read-
mitted to the hospital (34%) than those without an SSI (12%),
p<0.001. These rehospitalizations led to $7,925 charges per
person with an SSI compared with charges of $2,079 for those
without an SSI (p<0.001). After the conversion of charges to
costs, an SSI diagnosed after discharge was associated with
excess costs of $2,573 ($3,489 minus $916) from rehospital-
Table 2. Comparison of questionnaire responders to nonresponders, 
surgical site infection (SSI) studya
Characteristic
Responder 
N (% or SDa)
Nonresponder 
N (% or SDa)p  v a l u e
Study cohort N=267 173 94
Demographics
Age (yr) 58.2 (+/- 12.7) 54.6 (+/-15.2) 0.05b
Male gender 94 (54.3) 43 (45.7) 0.20c
Surgery duration (min) 152 (+/-91) 139 (+/- 98) 0.14d
Surgery type
 Cardiac 55 (31.8) 24 (25.5) 0.33c
 General 53 (30.6) 25 (26.6) 0.57c
 Gynecology 4 (2.3) 2 (2.1) 1.0c
 Neurology 7 (4.1) 5 (5.3) 0.76c
 Orthopedic 30 (17.3) 17 (18.1) 0.89c
 Other 1 (0.6) 4 (4.3) 0.054c
 Plastic 5 (2.9) 6 (6.4) 0.20c
 Urology 5 (2.9) 4 (4.3) 0.72c
 Vascular 13 (7.5) 7 (7.5) 1.0c
aResults are shown as no. (%) or mean +/- SD, along with p value for comparison of 
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ization across the entire population who developed an SSI,
regardless of readmission status.
Total estimated costs per person incurred during the 8
weeks after discharge from the hospital associated with the
index procedures were $5,155 for case-patients with SSI and
$1,773 for controls without an SSI (p<0.001). Therefore, costs
were $3,382 or 2.9 times greater in patients with SSI recog-
nized after discharge. The subsets of these costs that occurred
in those 216 patients never readmitted to any hospital (includ-
ing the index hospital) were, on average, $928 in case-patients
and $621 in controls (p<0.001). Therefore, patients with SSI
had on average $307 additional costs that would not have been
captured by an infection control surveillance system limited to
the inpatient setting. Additionally, in this particular cohort of
patients, 23% of all re-admissions and 18% of all emergency
room visits occurred at institutions other than the index hospi-
tal; such visits and admissions would not have been captured
by standard inpatient infection control surveillance. 
The mean chronic disease score was significantly higher
among case-patients (3,058) than controls (2,148) (p=0.005),
as expected on the basis of the higher prevalence of selected
chronic diseases in those at risk for an SSI. To determine if
preexisting conditions could account for some of the costs
associated with SSI recognized after discharge, we used a
matched linear regression model; the calculated chronic dis-
ease score was the predictor for log-transformed total costs
(Table 5). Although the chronic disease score was a strong
independent predictor of postoperative resource use, even in
this matched cohort, it was not a meaningful confounder of the
impact of SSI on resource utilization. The parameter estimate
for being a case was 1.30 for log-transformed costs in the
unadjusted model and 1.20 for log-transformed costs in the
adjusted model when chronic disease score was included. This
finding suggests that, even after preexisting conditions are
adjusted for, SSIs recognized after hospital discharge are sig-
nificantly associated with higher total costs. 
Even though we matched case-patients and controls on
duration of index surgery, patients with SSI recognized after
hospital discharge had significantly longer duration of surgery.
To measure if duration of index surgery could confound the
total attributable costs of SSI recognized after hospital dis-
charge, we used a matched linear regression model with dura-
tion of index surgery and SSI as predictors for log-transformed
total costs. The addition of duration of index surgery into the
model did not significantly confound the attributable impact
that SSI had on higher total costs (Table 5).
Discussion
SSIs recognized after discharge from the hospital were
associated with significantly higher direct medical costs and
indirect costs. With respect to direct medical costs, SSIs diag-
nosed after hospital discharge incurred significantly more
attributable use of resources than matched controls in each of
the following categories: outpatient visits, inpatient care, phar-
macy, radiology, home health aide care, and durable medical
equipment. When all sources of direct medical costs were
combined, SSIs recognized after discharge were associated
with $3,382 in excess costs over those without SSI. This dif-
ference was significant after preexisting conditions and index
surgery duration were controlled for. Importantly, in the linear
regression models (Table 5), SSIs recognized after discharge
explained one-half the variation in total costs (R2=0.49), and
this finding was not altered by the addition of chronic disease
score or index surgery duration.
Direct medical costs have been postulated to be low in
patients who do not require readmission after a postdischarge
SSI has developed (10). When readmission costs attributable
to SSI ($2,573) were subtracted from total costs attributable to
SSI ($3,382), we found that the mean charge manifest outside
of the inpatient hospital setting attributable to SSI recognized
after discharge was $809. Therefore, 24% of costs attributable
to the SSI recognized after discharge would typically occur
beyond the cost accounting systems of most index hospitals in
which the initial surgical procedure was performed. This 24%
would be the minimum fraction of the costs missed if all read-
missions occurred at the index hospital. In our study, 23% of
Table 3. Univariate analysis of questionnaire respondents, surgical 
site infections (SSIs) studya
Case-patient
N (% or SDa) 
(N=50)
Control 
N (% or SDa) 
(N=123) p value
HRQOL with SF-12
Preoperative MCS-12 51.7 (+/-9.6) 51.5 (+/-9.9) 0.96b
Postoperative MCS-12 47.6 (11.6) 52.4 (+/-9.2) 0.025b
Preoperative PCS-12 41.1 (+/-12.7) 45.0 (+/-10.9) 0.058b
Postoperative PCS-12 33.9 (+/-10.0) 38.7 (+/-9.8) 0.003b
Change MCS-12 with surgery –4.1 (+/-11.0) 0.9 (+/-9.6) 0.004b
Change PCS-12 with surgery –7.2 (+/-10.6) –6.3 (+/-13.3) 0.67b
Additional questions
Time and productivity costs
 If employed, missed work 66.7% 62.3% 0.81c
 Average no. missed days at work 61.2 (+/-38.6) 57.5 (+/-40.6) 0.95c
 Unable to do regular activities 60.6% 69.5% 0.39c
 Missed activities, in bed >1/2 day 63.6% 41.8% 0.043c
 Average no. days missed activities 49.6 (+/-41.3) 50.1 (+/-42.0) 0.90d
Additional costs
 Provider made home visits 69.4% 47.5% 0.011c
 Could have used home visits 30.8% 12.8% 0.068c
 Used paid housekeeper 6.3% 5.8% 1.0c
 Used 24-hr hotline 12.2% 5.7% 0.20c
 Could have used 24-hr hotline 21.4% 8.9% 0.052c
aResults are shown as mean (+/- SD) or % of total responders, along with p value for 
comparison of cases with SSIs to controls without SSIs. Abbreviations used: HRQOL, 
Health Related Quality of Life; SF-12, Medical Outcomes Study 12-Item Short-Form 
Health Survey; MCS, Mental Health Component Score of SF-12; PCS, Physical Health 
Component Score of SF-12.
bStudent t test. 
cFisher exact test.
dWilcoxon rank-sum test.Emerging Infectious Diseases  •  Vol. 9, No. 2, February 2003 201
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the readmissions occurred at settings other than the index hos-
pital. Therefore, approximately $1,409 (42%) of all costs
attributable to SSI were unknown to the index hospital. Kirk-
land et al. found that patients with an SSI had an increased risk
of readmission and death associated with SSIs recognized dur-
ing the initial hospitalization (11). No patients in our study
died during the 8-week postdischarge follow-up period.
The matched cohort-design has been associated with selec-
tion bias when stringent matching criteria prevent some cases
of SSI from being included in the study analysis (24,25).
Selection bias was not a factor in this study because all cases
of SSI were included.
We recognize that we were unable to assess all societal
costs of SSI, such as individual patient transportation costs.
Table 4. Univariate analysis of 8-week postoperative resource utilization, surgical site infections (SSIs) studya




or proportions Means p value
Outpatient visit use
Required outpatient visit 85 (96) 153 (86) <0.001b
Outpatient visits per patient 5 [4, 9] 7.5 (+/-6.3) 3 [1, 5] 3.4 (+/-3.0) <0.02c
Estimated outpatient visit costs $265 [$223, $430] $365 (+/-264) $146 [$63, $229] $160(+/-128) <0.001c
Lab test ordered by provider 69 (78) 143 (80) 0.66b
No. of lab tests ordered 1 [1, 3] 2.1 (+/-2.5) 1 [1, 2] 2.0 (+/-2.3) 0.58c
Patient phoned provider 77 (87) 125 (70) 0.002b
No. of phone calls made 3 [2, 6] 4.7 (+/-4.8) 1 [0, 4] 3.0 (+/-3.8) 0.00c
Pharmacy use
Standard wholesale costs  for antibiotics per patient $34.2 [$78.6, 10.6] $60 (+/-71.6) $0 [$0, $0] $13.6 (44.2) <0.001c
Emergency room use
Patient visits to emergency room 28 (31) 16 (9) <0.001b
Emergency room charges per patient $0 [$0, $370] $333 (+/-729) $0 [$0, $0] $114 (+/-470) <0.001c
Radiology services use
Patients who had a radiologic test 36 (40) 49 (28) 0.023b
Radiology charges per patient $0 [$0, $242] $1,076 (+/-3,845) $0 [$0, 124] $587 (+/-2,365) 0.022c
Rehospitalization 
Patients rehospitalized 30 (34) 21 (12) <0.001b
Total rehospitalization charges $0 [$0, $4,370] $7,925 (+/-22,321) $0[$0, $0] $2,079 (+/-11,222) <0.001c
Total rehospitalization costs $0 [$0, $1,924] $3,489 (+/-9,827) $0[$0, $0] $916 (+/-4,941) <0.001c
Visited by provider in hospital 46(52) 61(34) 0.008b
Inpatient provider visits 1 [0, 6] 3.5 (+/-4.5) 0 [0, 3] 2.2 (+/-5.3) <0.001c
Skilled nursing facility use
Skilled nursing facility used 8 (9) 8 (4.5) 0.09b
Days in skilled nursing facility 0 [0, 0] 0.21 (+/-0.83) 0 [0, 0] .21 (+/-1.8) 0.97c
Skilled nursing charges per patient $0 [$0, $0] $460 (+/-2,198) $0 [$0, $0] $204 (+/-1,651) 0.14c
Home health aide use
Home health aide used 55 (62) 84 (47) 0.009b
Home health charges per patient $110 [$0, $605] $827 (+/-1,765) $0 [$0, $275] $579 (+/-2,812) 0.007c
Durable equipment use
Durable medical equipment used 33 (37) 39 (22) 0.008b
Durable medical charges per patient $0 [$0, $102] $123 (+/-436) $0 [$0, $0] $69 (+/-223) 0.013c
Total costsd $1,240 [$445, $4,594] $5,155 (+/-10,8570 $300 [$146, $795] $1,773 (+/-6,344) <0.001c
aResults are shown as no. (%), mean (+/- standard deviation) or median [interquartile range] along with p value for comparison of cases with SSI to controls without SSI.
bCohran-Mantel-Haenszel.
c Wilcoxon signed-ranks test.
dTotal costs encompass all emergency, radiology, readmission, skilled nursing, home health, and durable medical charges that have been converted to costs with a cost-to-charge ratio 
and all estimated outpatient visit and antibiotic costs. RESEARCH
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However, in addition to the direct medical costs, we found that
patients with SSI recognized after discharge had a significant
decline in the mental health component of the SF-12. The
magnitude of this drop, compared to results for controls, was
similar to one reported for those who have experienced their
first myocardial infarction (26). Case-patients were also more
likely to spend more than one-half day in bed, missing their
regular activities. The economic impact of spending this extra
time in bed, however, appears to be minimal since we found no
significant differences in other measures of productivity. The
indirect costs of lost time at work could not be determined in
this cohort since fewer than one-third of respondents were
employed at the time of the study. A similar magnitude of use
of home health aide providers was reported in the question-
naire and in the electronic claims database. This correspon-
dence provides some evidence that respondents were
representative of the entire cohort. Although patients were not
asked about their use of resources in the 4 weeks before sur-
gery until weeks after the surgery took place, we have found
that for scaled scores, such as the SF-12 used in this study,
patients consistently reported similar results during the hospi-
tal stay and 3 months later (27).
We conclude that SSIs diagnosed after hospital discharge
were associated with significant impairment of physical and
mental health. These SSIs also incurred substantial excess
resource utilization across the spectrum of health care. These
findings support the need to prevent SSIs that occur after dis-
charge.
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